MSN Laboratories initiates phase-III trial of Molnupiravir

Clinical trials will be performed on more than 2,400 subjects suffering from mild-to-moderate Covid-19

Comments

Popular posts from this blog

Viral video involving woman cop sparks controversy, plaint filed

Infosys lays off hundreds after failing internal assessments in Mysuru

Congress groomed me not to sit at home: Shivakumar